Survival of TP53-Mutated Acute Myeloid Leukemia Patients Receiving Allogeneic Stem Cell Transplantation after First Induction or Salvage Therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

By
Jamie Kang
-
0
97
Investigators conducted a multi-center study to analyze factors predicting survival among patients with TP53-mutated AML receiving allogeneic hematopoietic stem cell transplant in the recent era.
[Leukemia]
Full Article